UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial

The Journal of infectious diseases, 2016-10, Vol.214 (8), p.1276-1283

2016

Volltextzugriff (PDF)

Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men

Vaccine, 2019-04, Vol.37 (18), p.2502-2510

2019

Volltextzugriff (PDF)

The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer

International journal of cancer, 2015-12, Vol.137 (12), p.2846-2857

2015

Volltextzugriff (PDF)

Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion

Virology journal, 2024-08, Vol.21 (1), p.172-13, Article 172

2024

Volltextzugriff (PDF)

Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes

Journal of virology, 2014-04, Vol.88 (8), p.4173-4179

2014

Volltextzugriff (PDF)

Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)

AIDS research and therapy, 2017-07, Vol.14 (1), p.34-34, Article 34

2017

Volltextzugriff (PDF)

Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8 + T Cells in Head and Neck Cancer

Cancer research (Chicago, Ill.), 2018-11, Vol.78 (21), p.6159-6170

2018

Volltextzugriff (PDF)

Immunological tolerance of low‐risk HPV in recurrent respiratory papillomatosis

Clinical and experimental immunology, 2020-02, Vol.199 (2), p.131-142

2020

Volltextzugriff (PDF)

A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2

Journal of Virology, 2007-12, Vol.81 (24), p.13927-13931

2007

Volltextzugriff (PDF)

An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study

Cancer epidemiology, biomarkers & prevention, 2018-04, Vol.27 (4), p.496-502

2018

Volltextzugriff (PDF)

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8 + Memory T Cells

The Journal of immunology (1950), 2019-02, Vol.202 (4), p.1250-1264

2019

Volltextzugriff (PDF)

Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Clinical and Vaccine Immunology, 2012-02, Vol.19 (2), p.261-267

2012

Volltextzugriff (PDF)

Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity

PloS one, 2016-03, Vol.11 (3), p.e0152886

2016

Volltextzugriff (PDF)

Population-level impact of human papillomavirus vaccination

The Lancet (British edition), 2020-02, Vol.395 (10222), p.412-412

2020

Volltextzugriff (PDF)

MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7

Vaccine, 2015-06, Vol.33 (28), p.3164-3170

2015

Volltextzugriff (PDF)

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000373-e1000373

2009

Volltextzugriff (PDF)

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Journal of adolescent health, 2009, Vol.44 (1), p.33-40

2009

Volltextzugriff (PDF)

Dual T cell receptor/chimeric antigen receptor engineered NK‐92 cells targeting the HPV16 E6 oncoprotein and the tumor‐associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells

Journal of medical virology, 2024-05, Vol.96 (5), p.e29630-n/a

2024

Volltextzugriff (PDF)

The interplay between HPV and host immunity in head and neck squamous cell carcinoma

International journal of cancer, 2014-06, Vol.134 (12), p.2755-2763

2014

Volltextzugriff (PDF)

A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers

The Journal of biological chemistry, 2010-09, Vol.285 (38), p.29608-29622

2010

Volltextzugriff (PDF)

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells

International journal of nanomedicine, 2019-01, Vol.14, p.8755-8768

2019

Volltextzugriff (PDF)

HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men

Vaccine, 2019-05, Vol.37 (21), p.2864-2869

2019

Volltextzugriff (PDF)

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus

PloS one, 2014-05, Vol.9 (5), p.e96579

2014

Volltextzugriff (PDF)

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

Virology (New York, N.Y.), 2007-02, Vol.358 (2), p.266-272

2007

Volltextzugriff (PDF)

1 – 25 von 530

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(497)
Mit Volltextzugriff
(459)

Publikationsform

Artikel
(529)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(485)
Life Sciences & Biomedicine
(465)
Humans
(406)
Human Papillomavirus 16
(266)
Human Papillomavirus
(259)
Immunology
(246)
Animals
(204)
Mice
(164)
Human Papillomavirus 16 - Immunology
(159)
Virology
(156)
Biological And Medical Sciences
(148)
Oncogene Proteins, Viral - Immunology
(136)
Microbiology
(127)
Male
(115)
Vaccines
(113)
Oncogene Proteins, Viral - Genetics
(106)
Papillomavirus Infections - Immunology
(105)
Fundamental And Applied Biological Sciences. Psychology
(102)
Papillomavirus Infections - Prevention & Control
(96)
Papillomaviridae - Immunology
(93)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(494)
EZB Electronic Journals Library
(316)
Ingenta
(269)
Journals@Ovid Full Text
(166)
Elsevier ScienceDirect Journals
(124)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(115)
IngentaConnect Journals
(114)
Publisher or Other Site
(93)
Springer journals
(71)
Wiley Online Library
(46)
Wiley Online Library
(38)
Oxford journals
(37)
JSTOR
(36)
Oxford Journals 2020 Medicine
(32)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(30)
Springer Nature - Connect here FIRST to enable access
(19)
Taylor & Francis Journals
(18)
Taylor & Francis
(16)
Taylor & Francis Online
(14)
Nexis Uni
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial

Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men

The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer

Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion

Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes

Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)

Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8 + T Cells in Head and Neck Cancer

Immunological tolerance of low‐risk HPV in recurrent respiratory papillomatosis

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2

An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8 + Memory T Cells

Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity

Population-level impact of human papillomavirus vaccination

MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Dual T cell receptor/chimeric antigen receptor engineered NK‐92 cells targeting the HPV16 E6 oncoprotein and the tumor‐associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells

The interplay between HPV and host immunity in head and neck squamous cell carcinoma

A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells

HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

Aktive Filter

Suchergebnisse filtern